Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Sara Reed

16 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5110741678

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 11 Mechanism of Action 6 Depression 5 Neuroplasticity 5 OCD 4 Review Article 4 Brain Imaging 4 Animal Study 4 Anxiety 3 Eating Disorders 3 Pharmacology 3 Clinical Trial 3

Journals

Physiology & behavior 2 Cureus 2 Nature medicine 1 CNS drugs 1 Comprehensive psychiatry 1 International review of neurobiology 1 Trends in pharmacological sciences 1 Neuropsychiatric disease and treatment 1

Publication history

Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01 Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01 Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.Physiology & behavior · 2025-09-01 Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosaPhysiology & behavior · 2025-09-01 Serotonergic psychedelics for depression: A comprehensive overview.International review of neurobiology · 2025-01-01 Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Do the therapeutic effects of psilocybin involve actions in the gut?Trends in pharmacological sciences · 2024-02-01 Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Neuropsychiatric disease and treatment · 2024-01-01 Peer support and psychedelics.Journal of military, veteran and family health · 2023-12-01 Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-05 Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07 Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 1990-04-01 A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.The Journal of pharmacology and experimental therapeutics · 1974-03-30 Tolerance and cross-tolerance among psychotomimetic drugs.Psychopharmacologia · 1968-08-30

Author directory